191
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Cytoproliferative effect of low dose alpha radiation in human lung cancer cells is associated with connexin 43, caveolin-1, and survivin pathway

& ORCID Icon
Pages 356-366 | Received 30 Jan 2020, Accepted 08 Dec 2020, Published online: 08 Jan 2021

References

  • Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A, Ekström TJ, Almqvist PM. 2003. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res. 284(2):185–195.
  • Azzam EI, de Toledo SM, Little JB. 2001. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 98(2):473–478.
  • Azzam EI, de Toledo SM, Little JB. 2004. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets. 4(1):53–64.
  • Belchior A, Gil OM, Almeida P, Vaz P. 2012. Dose and time dependence of targeted and untargeted effects after very low doses of α-particle irradiation of human lung cancer cells. Dose Response. 11(3):431–446.
  • Bell ES, Coelho PP, Ratcliffe CDH, Rajadurai CV, Peschard P, Vaillancourt R, Zuo D, Park M. 2019. LC3C-mediated autophagy selectively regulates the Met RTK and HGF-stimulated migration and invasion. Cell Rep. 29(12):4053–4068.e6.
  • Chandna S, Dwarakanath BS, Khaitan D, Lazar Mathew T, Jain V. 2002. Low-dose radiation hypersensitivity in human tumor cell lines: effects of cell–cell contact and nutritional deprivation. Radiat Res. 157(5):516–525.
  • Cherubini R, de Nadal V, Gerardi S. 2015. Hyper-radiosensitivity and induced radioresistance and bystander effects in rodent and human cells as a function of radiation quality. Radiat Prot Dosimetry. 166(1-4):137–141.
  • Coussens LM, Werb Z. 2020. Inflammation and cancer. Nature. 420(6917):860–867.
  • Desai S, Kumar A, Laskar S, Pandey BN. 2013. Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells. Cytokine. 61(1):54–62.
  • Desai S, Laskar S, Pandey BN. 2013. Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells. Cell Signal. 25(9):1780–1791.
  • Desai S, Srambikkal N, Yadav HD, Shetake N, Balla MMSS, Kumar A, Ray P, Ghosh A, Pandey BN. 2016. Molecular understanding of growth inhibitory effect from irradiated to bystander tumor cells in mouse fibrosarcoma tumor model. PLoS One. 11(8):e0161662.
  • Elgqvist J, Frost S, Pouget J, Albertsson P. 2014. The potential and hurdles of targeted alpha therapy - clinical trials and beyond. Front Oncol. 3:324.
  • Elgqvist J, Timmermand OV, Larsson E, Strand SE. 2016. Radiosensitivity of prostate cancer cell lines for irradiation from beta particle-emitting radionuclide 177Lu compared to alpha particles and gamma rays. Anticancer Res. 36(1):103–109.
  • Fowler JF. 1990. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys. 18(5):1261–1269.
  • Huang C-Y, Guatelli S, Oborn BM, Allen BJ. 2011. Background dose for systemic targeted alpha therapy. Prog Nucl Sci Technol. 2(0):187–190.
  • Huang CY, Guatelli S, Oborn BM, Allen BJ. 2012. Microdosimetry for targeted alpha therapy of cancer. Comput Math Methods Med. 2012:153212.
  • Iyer R, Lehnert BE, Svensson R. 2000. Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res. 60(5):1290–1298.
  • Jyothish Babu MV, Shinde SG, Sunil Kumar S, Ali M, Vasumathy R, Kumar A, Kolekar RV, Kumar M, Nema PK, Bhagwat PV, et al. 2013. Dosimetry and radiobiological studies of automated alpha-particle irradiator. J Environ Pathol Toxicol Oncol. 32(3):263–273.
  • Kanagaraj K, Rajan V, Pandey BN, Thayalan K, Venkatachalam P. 2019. Primary and secondary bystander effect and genomic instability in cells exposed to high and low linear energy transfer radiations. Int J Radiat Biol. 95(12):1648–1658.
  • Karthik K, Rajan V, Pandey BN, Sivasubramanian K, Paul SFD, Venkatachalam P. 2019. Direct and bystander effects in human blood lymphocytes exposed to 241Am alpha particles and the relative biological effectiveness using chromosomal aberration and micronucleus assay. Int J Radiat Biol. 95(6):725–736.
  • Kozempel J, Mokhodoeva O, Vlk M. 2018. Progress in targeted alpha-particle therapy. What we learned about recoils release from in vivo generators. Molecules. 23(3):581.
  • Kühne K, Rothkamm M, Löbrich M, Rothkamm K, Löbrich M. 2000. No dose-dependence of DNA double-strand break misrejoining following alpha-particle irradiation. Int J Radiat Biol. 76(7):891–900.
  • Kumar C, Shetake N, Desai S, Kumar A, Samuel G, Pandey BN. 2016. Relevance of radiobiological concepts in radionuclide therapy of cancer. Int J Radiat Biol. 92(4):173–186.
  • Langlois S, Cowan KN, Shao Q, Cowan BJ, Laird DW. 2008. Caveolin-1 and -2 interact with connexin 43 and regulate gap junctional intercellular communication in keratinocytes. Mol Biol Cell. 19(3):912–928.
  • Lee J, Choi JH, Joo CK. 2013. TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin. Cell Death Dis. 4(7):e714
  • Leung CN, Canter BS, Rajon D, Back TA, Fritton JC, Azzam EI, Howell RW. 2020. Dose-dependent growth delay of breast cancer xenografts in the bone marrow of mice treated with 223Ra: the role of bystander effects and their potential for therapy. J Nucl Med. 61(1):89–95.
  • Little JB, Nagasawa H, de Toledo SM, Azzam E. 2002. Transmission of damage signals from irradiated to nonirradiated cells. Int Congr Ser. 1236(C):229–235.
  • Locke D, Liu J, Harris AL. 2005. Lipid rafts prepared by different methods contain different connexin channels, but gap junctions are not lipid rafts. Biochemistry. 44(39):13027–13042.
  • Metting NF, Koehler AM, Nagasawa H, Nelson JM, Little JB. 1995. Design of a benchtop alpha particle irradiator. Heal Phys. 68(5):710–715.
  • Neti PV, de Toledo SM, Perumal V, Azzam EI, Howell RW. 2004. A multi-port low-fluence alpha-particle irradiator: fabrication, testing and benchmark radiobiological studies. Radiat Res. 161(6):732–738.
  • Riquier H, Abel D, Wera A-C, Heuskin A-C, Genard G, Lucas S, Michiels C. 2015. Effects of alpha particle and proton beam irradiation as putative cross-talk between A549 cancer cells and the endothelial cells in a co-culture system. Cancers (Basel). 7(1):481–502.
  • Riquier H, Wera A-C, Heuskin A-C, Feron O, Lucas S, Michiels C. 2013. Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: survival curves and gene expression profiles. Radiother Oncol. 106(3):397–403.
  • Schubert AL, Schubert W, Spray DC, Lisanti MP. 2002. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41(18):5754–5764.
  • Shetake NG, Kumar A, Pandey BN. 2019. Iron-oxide nanoparticles target intracellular HSP90 to induce tumor radio-sensitization. Biochim Biophys Acta Gen Subj. 1863(5):857–869.
  • Skarsgard LD. 1998. Radiobiology with heavy charged particles: a historical review. Phys Med. 14(Suppl 1):1–19.
  • Todoric J, Karin M. 2019. The fire within: cell-autonomous mechanisms in inflammation-driven cancer. Cancer Cell. 35(5):714–720.
  • Torres VA, Tapia JC, Rodríguez DA, Párraga M, Lisboa P, Montoya M, Leyton L, Quest AFG. 2006. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci. 119:1812–1823.
  • Vaughan AT, Bradwell AR, Dykes PW, Anderson P. 1986. Illusions of tumour killing using radiolabelled antibodies. Lancet. 327(8496):1492–1493.
  • Weinberg RA. 2013. The biology of cancer. 2nd edn. New York (NY): Garland Science.
  • Yard BD, Gopal P, Bannik K, Siemeister G, Hagemann UB, Abazeed ME. 2019. Cellular and genetic determinants of the sensitivity of cancer to α-particle irradiation. Cancer Res. 79(21):5640–5651.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.